A prognostic index model for predicting overall survival in patients with metastatic castration-resistant prostate cancer treated with abiraterone acetate after docetaxel-Reference-Cited by-同舟云学术

A prognostic index model for predicting overall survival in patients with metastatic castration-resistant prostate cancer treated with abiraterone acetate after docetaxel

Published:2016-03 Issue:3 Volume:27 Page:454-460
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Chi K.N.,Kheoh T.,Ryan C.J.,Molina A.,Bellmunt J.,Vogelzang N.J.,Rathkopf D.E.,Fizazi K.,Kantoff P.W.,Li J.,Azad A.A.,Eigl B.J.,Heng D.Y.C.,Joshua A.M.,de Bono J.S.,Scher H.I.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/27/3/454/16699810/mdv594.pdf

Reference34 articles.

1. International Agency for Research on Cancer. Prostate cancer: estimated incidence, mortality, and prevalence worldwide. GLOBOCAN Web site. http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx (20 March 2014, date last accessed).

2. Prostate cancer: a practical approach to current management of recurrent disease;Walczak;Mayo Clin Proc,2007

3. Castration-resistant prostate cancer: from new pathophysiology to new treatment targets;Chi;Eur Urol,2009

4. Enzalutamide in metastatic prostate cancer before chemotherapy;Beer;N Engl J Med,2014

5. Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial;de Bono;Lancet,2010

Cited by 140 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interlesional response heterogeneity is associated with the prognosis of abiraterone treatment in metastatic castration-resistant prostate cancer;Med;2024-08

2. Androgens exert multifaceted functions in sex differences analyzed through single-cell transcriptome;Science China Life Sciences;2024-06-26

3. Bellmunt risk score as a survival predictor in patients with metastatic castration‐resistant prostate cancer;The Prostate;2024-05-15

4. Fluorine-18 prostate-specific membrane antigen-1007-avid indeterminate bone lesions in prostate cancer: clinical and PET/CT features to predict outcomes and prognosis;Clinical Radiology;2024-05

5. From biology to the clinic — exploring liver metastasis in prostate cancer;Nature Reviews Urology;2024-04-26